Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 1:41 AM
NCT ID:
NCT05083494
Eligibility Criteria:
Inclusion Criteria:
* Patients starting anti-PD1 immunotherapy as part of marketing authorization alone or in combination (melanoma, clear cell renal cancer, urothelial carcinomas of the bladder, squamous cell carcinomas of the head and neck and non-small cell lung cancer).
* No contraindications to immunotherapy
* Non-pregnant patient
* Patient not opposed to participation in this study
Exclusion Criteria:
* HIV seropositivity
* Patient with psychiatric or other conditions that may compromise his or her ability to give non opposition or to follow study procedures
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05083494
Study Brief:
Protocol Section:
NCT05083494